Medicare and Medicaid Programs; Application From The Joint Commission (TJC) for Continued CMS-Approval of Its Ambulatory Surgical Center (ASC) Accreditation Program, 31511-31513 [2020-11234]
Download as PDF
Federal Register / Vol. 85, No. 101 / Tuesday, May 26, 2020 / Notices
Seema Verma, having reviewed and
approved this document, authorizes
Evell J. Barco Holland, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: April 21, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of
Health and Human Services.
[FR Doc. 2020–11235 Filed 5–22–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–317]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
July 27, 2020.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
SUMMARY:
VerDate Sep<11>2014
19:08 May 22, 2020
Jkt 250001
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Numberl, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–317 State Medicaid Eligibility
Quality Control (MEQC) Sample Plans
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
31511
Information Collection
1. Type of Information Collection
Request: Reinstatement without change
of a previously approved collection of
information; Title of Information
Collection: State Medicaid Eligibility
Quality Control Sampling Plan; Use:
The Medicaid Eligibility Quality Control
(MEQC) program provides states and the
District of Columbia a unique
opportunity to improve the quality and
accuracy of their Medicaid and
Children’s Health Insurance Program
(CHIP) eligibility determinations. The
MEQC program is intended to
complement the Payment Error Rate
Measurement (PERM) program by
ensuring state operations make accurate
and timely eligibility determinations so
that Medicaid and CHIP services are
appropriately provided to eligible
individuals. Current regulations require
that states review equal numbers of
active cases and negative case actions
(i.e., denials and terminations) through
random sampling. Active case reviews
are conducted to determine whether or
not the sampled cases meet all current
criteria and requirements for Medicaid
or CHIP eligibility. Negative case
reviews are conducted to determine if
Medicaid and CHIP denials and
terminations were appropriate and
undertaken in accordance with due
process. Form Number: CMS–317 (OMB
control number: 0938–0146); Frequency:
Occasionally; Affected Public: State,
Local, or Tribal Governments; Number
of Respondents: 10; Total Annual
Responses: 20; Total Annual Hours:
520. (For policy questions regarding this
collection contact Camiel Rowe at 410–
786–0069.)
Dated: May 19, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2020–11161 Filed 5–22–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3397–PN]
Medicare and Medicaid Programs;
Application From The Joint
Commission (TJC) for Continued CMSApproval of Its Ambulatory Surgical
Center (ASC) Accreditation Program
Centers for Medicare and
Medicaid Services (CMS), HHS.
AGENCY:
E:\FR\FM\26MYN1.SGM
26MYN1
31512
Federal Register / Vol. 85, No. 101 / Tuesday, May 26, 2020 / Notices
I. Background
Notice with request for
comment.
ACTION:
This proposed notice
acknowledges the receipt of an
application from The Joint Commission
for continued recognition as a national
accrediting organization for Ambulatory
Surgical Centers that wish to participate
in the Medicare or Medicaid programs.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on June 25, 2020.
ADDRESSES: In commenting, refer to file
code CMS–3397–PN. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–3397–PN, P.O. Box 8010,
Baltimore, MD 21244–8010.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–3397–PN,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Erin Imhoff, (410) 786–2337.
Joy Webb, (410) 786–1667.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
www.regulations.gov. Follow the search
instructions on that website to view
public comments.
SUMMARY:
VerDate Sep<11>2014
19:08 May 22, 2020
Jkt 250001
Ambulatory Surgical Centers (ASCs)
are distinct entities that operate
exclusively for the purpose of
furnishing outpatient surgical services
to patients. Under the Medicare
program, eligible beneficiaries may
receive covered services from an ASC
provided certain requirements are met.
Section 1832(a)(2)(F)(i) of the Social
Security Act (the Act) establishes
distinct criteria for a facility seeking
designation as an ASC. Regulations
concerning provider agreements are at
42 CFR part 489 and those pertaining to
activities relating to the survey and
certification of facilities are at 42 CFR
part 488. The regulations at 42 CFR part
416 specify the conditions that an ASC
must meet in order to participate in the
Medicare program, the scope of covered
services, and the conditions for
Medicare payment for ASCs.
Generally, to enter into an agreement,
an ASC must first be certified by a State
survey agency (SA) as complying with
the conditions or requirements set forth
in part 416 of our Medicare regulations.
Thereafter, the ASC is subject to regular
surveys by an SA to determine whether
it continues to meet these requirements.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by a Centers for
Medicare & Medicaid Services (CMS)
approved national accrediting
organization (AO) that all applicable
Medicare conditions are met or
exceeded, we may deem that provider
entity as having met the requirements.
Accreditation by an AO is voluntary and
is not required for Medicare
participation.
If an AO is recognized by the
Secretary of the Department of Health
and Human Services as having
standards for accreditation that meet or
exceed Medicare requirements, any
provider entity accredited by the
national accrediting body’s approved
program may be deemed to meet the
Medicare conditions. The AO applying
for approval of its accreditation program
under part 488, subpart A, must provide
CMS with reasonable assurance that the
AO requires the accredited provider
entities to meet requirements that are at
least as stringent as the Medicare
conditions. Our regulations concerning
the approval of AOs are set forth at
§ 488.5.
The Joint Commission’s (TJC’s)
current term of approval for its ASC
program expires December 20, 2020.
II. Approval of Deeming Organization
Section 1865(a)(2) of the Act and
§ 488.5 require that our findings
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
concerning review and approval of an
AO’s requirements consider, among
other factors, the applying AO’s
requirements for accreditation; survey
procedures; resources for conducting
required surveys; capacity to furnish
information for use in enforcement
activities; monitoring procedures for
provider entities found not in
compliance with the conditions or
requirements; and ability to provide
CMS with the necessary data for
validation.
Section 1865(a)(3)(A) of the Act
further requires that we publish, within
60 days of receipt of an organization’s
complete application, a notice
identifying the national accrediting
body making the request, describing the
nature of the request, and providing at
least a 30-day public comment period.
We have 210 days from the receipt of a
complete application to publish notice
of approval or denial of the application.
The purpose of this proposed notice
is to inform the public of TJC’s request
for continued CMS-approval of its ASC
accreditation program. This notice also
solicits public comment on whether
TJC’s requirements meet or exceed the
Medicare conditions for coverage (CfCs)
for ASCs.
III. Evaluation of Deeming Authority
Request
TJC submitted all the necessary
materials to enable us to make a
determination concerning its request for
continued CMS-approval of its ASC
accreditation program. This application
was determined to be complete on
March 24, 2020. Under section
1865(a)(2) of the Act and § 488.5, our
review and evaluation of TJC will be
conducted in accordance with, but not
necessarily limited to, the following
factors:
b The equivalency of TJC’s standards
for ASCs as compared with Medicare’s
CfCs for ASCs.
b TJC’s survey process to determine
the following:
++ The composition of the survey
team, surveyor qualifications, and the
ability of the organization to provide
continuing surveyor training.
++ The comparability of TJC’s
processes to those of State agencies,
including survey frequency, and the
ability to investigate and respond
appropriately to complaints against
accredited facilities.
++ TJC’s processes and procedures
for monitoring an ASC found out of
compliance with TJC’s program
requirements. These monitoring
procedures are used only when TJC
identifies noncompliance. If
noncompliance is identified through
E:\FR\FM\26MYN1.SGM
26MYN1
Federal Register / Vol. 85, No. 101 / Tuesday, May 26, 2020 / Notices
validation reviews or complaint
surveys, the State survey agency
monitors corrections as specified at
§ 488.9(c)(1).
++ TJC’s capacity to report
deficiencies to the surveyed facilities
and respond to the facility’s plan of
correction in a timely manner.
++ TJC’s capacity to provide CMS
with electronic data and reports
necessary for the effective validation
and assessment of the organization’s
survey process.
++ The adequacy of TJC’s staff and
other resources, and its financial
viability.
++ TJC’s capacity to adequately fund
required surveys.
++ TJC’s policies with respect to
whether surveys are announced or
unannounced, to ensure that surveys are
unannounced.
++ TJC’s policies and procedures to
avoid conflicts of interest, including the
appearance of conflicts of interest,
involving individuals who conduct
surveys or participate in accreditation
decisions.
++ TJC’s agreement to provide CMS
with a copy of the most current
accreditation survey together with any
other information related to the survey
as CMS may require (including
corrective action plans).
IV. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
V. Response to Public Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
Upon completion of our evaluation,
including our evaluation of comments
received as a result of this notice, we
will publish a final notice in the Federal
Register announcing the result of our
evaluation.
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Seema Verma, having reviewed and
approved this document, authorizes
VerDate Sep<11>2014
19:08 May 22, 2020
Jkt 250001
Evell J. Barco Holland, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: May 7, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of
Health and Human Services.
[FR Doc. 2020–11234 Filed 5–22–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2020–D–1136, FDA–
2020–D–1137, FDA–2020–D–1138, FDA–
2020–D–1139]
Guidance Documents Related to
Coronavirus Disease 2019 (COVID–19);
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of FDA
guidance documents related to the
Coronavirus Disease 2019 (COVID–19)
public health emergency (PHE). This
notice of availability (NOA) is pursuant
to the process that FDA announced, in
the Federal Register of March 25, 2020,
for making available to the public
COVID–19-related guidances. The
guidances identified in this notice
address issues related to the COVID–19
PHE and have been issued in
accordance with the process announced
in the March 25, 2020, notice. The
guidances have been implemented
without prior comment, but they remain
subject to comment in accordance with
the Agency’s good guidance practices.
DATES: The announcement of the
guidances is published in the Federal
Register on May 26, 2020. The
guidances have been implemented
without prior comment, but they remain
subject to comment in accordance with
the Agency’s good guidance practices.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
31513
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the name of the
guidance(s) that the comments address
and the docket number for the guidance
(see table 1). Received comments will be
placed in the docket(s) and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
E:\FR\FM\26MYN1.SGM
26MYN1
Agencies
[Federal Register Volume 85, Number 101 (Tuesday, May 26, 2020)]
[Notices]
[Pages 31511-31513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11234]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3397-PN]
Medicare and Medicaid Programs; Application From The Joint
Commission (TJC) for Continued CMS-Approval of Its Ambulatory Surgical
Center (ASC) Accreditation Program
AGENCY: Centers for Medicare and Medicaid Services (CMS), HHS.
[[Page 31512]]
ACTION: Notice with request for comment.
-----------------------------------------------------------------------
SUMMARY: This proposed notice acknowledges the receipt of an
application from The Joint Commission for continued recognition as a
national accrediting organization for Ambulatory Surgical Centers that
wish to participate in the Medicare or Medicaid programs.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. on June 25, 2020.
ADDRESSES: In commenting, refer to file code CMS-3397-PN. Because of
staff and resource limitations, we cannot accept comments by facsimile
(FAX) transmission.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-3397-PN, P.O. Box 8010,
Baltimore, MD 21244-8010.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-3397-PN, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Erin Imhoff, (410) 786-2337.
Joy Webb, (410) 786-1667.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following
website as soon as possible after they have been received: https://www.regulations.gov. Follow the search instructions on that website to
view public comments.
I. Background
Ambulatory Surgical Centers (ASCs) are distinct entities that
operate exclusively for the purpose of furnishing outpatient surgical
services to patients. Under the Medicare program, eligible
beneficiaries may receive covered services from an ASC provided certain
requirements are met. Section 1832(a)(2)(F)(i) of the Social Security
Act (the Act) establishes distinct criteria for a facility seeking
designation as an ASC. Regulations concerning provider agreements are
at 42 CFR part 489 and those pertaining to activities relating to the
survey and certification of facilities are at 42 CFR part 488. The
regulations at 42 CFR part 416 specify the conditions that an ASC must
meet in order to participate in the Medicare program, the scope of
covered services, and the conditions for Medicare payment for ASCs.
Generally, to enter into an agreement, an ASC must first be
certified by a State survey agency (SA) as complying with the
conditions or requirements set forth in part 416 of our Medicare
regulations. Thereafter, the ASC is subject to regular surveys by an SA
to determine whether it continues to meet these requirements.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by a Centers for Medicare & Medicaid
Services (CMS) approved national accrediting organization (AO) that all
applicable Medicare conditions are met or exceeded, we may deem that
provider entity as having met the requirements. Accreditation by an AO
is voluntary and is not required for Medicare participation.
If an AO is recognized by the Secretary of the Department of Health
and Human Services as having standards for accreditation that meet or
exceed Medicare requirements, any provider entity accredited by the
national accrediting body's approved program may be deemed to meet the
Medicare conditions. The AO applying for approval of its accreditation
program under part 488, subpart A, must provide CMS with reasonable
assurance that the AO requires the accredited provider entities to meet
requirements that are at least as stringent as the Medicare conditions.
Our regulations concerning the approval of AOs are set forth at Sec.
488.5.
The Joint Commission's (TJC's) current term of approval for its ASC
program expires December 20, 2020.
II. Approval of Deeming Organization
Section 1865(a)(2) of the Act and Sec. 488.5 require that our
findings concerning review and approval of an AO's requirements
consider, among other factors, the applying AO's requirements for
accreditation; survey procedures; resources for conducting required
surveys; capacity to furnish information for use in enforcement
activities; monitoring procedures for provider entities found not in
compliance with the conditions or requirements; and ability to provide
CMS with the necessary data for validation.
Section 1865(a)(3)(A) of the Act further requires that we publish,
within 60 days of receipt of an organization's complete application, a
notice identifying the national accrediting body making the request,
describing the nature of the request, and providing at least a 30-day
public comment period. We have 210 days from the receipt of a complete
application to publish notice of approval or denial of the application.
The purpose of this proposed notice is to inform the public of
TJC's request for continued CMS-approval of its ASC accreditation
program. This notice also solicits public comment on whether TJC's
requirements meet or exceed the Medicare conditions for coverage (CfCs)
for ASCs.
III. Evaluation of Deeming Authority Request
TJC submitted all the necessary materials to enable us to make a
determination concerning its request for continued CMS-approval of its
ASC accreditation program. This application was determined to be
complete on March 24, 2020. Under section 1865(a)(2) of the Act and
Sec. 488.5, our review and evaluation of TJC will be conducted in
accordance with, but not necessarily limited to, the following factors:
[ballot] The equivalency of TJC's standards for ASCs as compared
with Medicare's CfCs for ASCs.
[ballot] TJC's survey process to determine the following:
++ The composition of the survey team, surveyor qualifications, and
the ability of the organization to provide continuing surveyor
training.
++ The comparability of TJC's processes to those of State agencies,
including survey frequency, and the ability to investigate and respond
appropriately to complaints against accredited facilities.
++ TJC's processes and procedures for monitoring an ASC found out
of compliance with TJC's program requirements. These monitoring
procedures are used only when TJC identifies noncompliance. If
noncompliance is identified through
[[Page 31513]]
validation reviews or complaint surveys, the State survey agency
monitors corrections as specified at Sec. 488.9(c)(1).
++ TJC's capacity to report deficiencies to the surveyed facilities
and respond to the facility's plan of correction in a timely manner.
++ TJC's capacity to provide CMS with electronic data and reports
necessary for the effective validation and assessment of the
organization's survey process.
++ The adequacy of TJC's staff and other resources, and its
financial viability.
++ TJC's capacity to adequately fund required surveys.
++ TJC's policies with respect to whether surveys are announced or
unannounced, to ensure that surveys are unannounced.
++ TJC's policies and procedures to avoid conflicts of interest,
including the appearance of conflicts of interest, involving
individuals who conduct surveys or participate in accreditation
decisions.
++ TJC's agreement to provide CMS with a copy of the most current
accreditation survey together with any other information related to the
survey as CMS may require (including corrective action plans).
IV. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
V. Response to Public Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
Upon completion of our evaluation, including our evaluation of
comments received as a result of this notice, we will publish a final
notice in the Federal Register announcing the result of our evaluation.
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Seema Verma, having reviewed and approved this document,
authorizes Evell J. Barco Holland, who is the Federal Register Liaison,
to electronically sign this document for purposes of publication in the
Federal Register.
Dated: May 7, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of Health and Human Services.
[FR Doc. 2020-11234 Filed 5-22-20; 8:45 am]
BILLING CODE 4120-01-P